Literature DB >> 35689091

Dectin-1 plays a deleterious role in high fat diet-induced NAFLD of mice through enhancing macrophage activation.

Min-Xiu Wang1, Wu Luo1,2, Lin Ye1, Lei-Ming Jin1, Bin Yang1, Qian-Hui Zhang1, Jian-Chang Qian1, Yi Wang1, Yi Zhang3, Guang Liang4,5.   

Abstract

The innate immune response and inflammation contribute to hepatic steatosis and non-alcoholic fatty liver disease (NAFLD). Dectin-1 is a pathogen recognition receptor in innate immunity. In this study, we investigated the role of Dectin-1 in the pathogenesis of NAFLD. We first showed that Dectin-1 expression was significantly elevated in liver tissues of patients with NASH. NAFLD was induced in mice by feeding high fat diet (HFD) for 24 weeks. At the end of treatment, mice were sacrificed, and their blood and liver tissues were collected for analyses. We showed HFD feeding also increased liver Dectin-1 levels in mice, associated with macrophage infiltration. Either gene knockout or co-administration of a Dectin-1 antagonist laminarin (150 mg/kg twice a day, ip, from 16th week to 24th week) largely protected the livers from HFD-induced lipid accumulation, fibrosis, and elaboration of inflammatory responses. In primary mouse peritoneal macrophages (MPMs), challenge with palmitate (PA, 200 μM), an abundant saturated fatty acid found in NAFLD, significantly activated Dectin-1 signaling pathway, followed by transcriptionally regulated production of pro-inflammatory cytokines. Dectin-1 was required for hepatic macrophage activation and inflammatory factor induction. Condition media generated from Dectin-1 deficient macrophages failed to cause hepatocyte lipid accumulation and hepatic stellate activation. In conclusion, this study provides the primary evidence supporting a deleterious role for Dectin-1 in NAFLD through enhancing macrophage pro-inflammatory responses and suggests that it can be targeted to prevent inflammatory NAFLD.
© 2022. The Author(s), under exclusive licence to Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society.

Entities:  

Keywords:  Dectin-1; NF-κB; TGF-β1; inflammation; macrophages; non-alcoholic fatty liver disease

Year:  2022        PMID: 35689091     DOI: 10.1038/s41401-022-00926-2

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  48 in total

Review 1.  Targeting hepatic macrophages to treat liver diseases.

Authors:  Frank Tacke
Journal:  J Hepatol       Date:  2017-03-04       Impact factor: 25.083

2.  The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.

Authors:  Zobair M Younossi; Pegah Golabi; Leyla de Avila; James Minhui Paik; Manirath Srishord; Natsu Fukui; Ying Qiu; Leah Burns; Arian Afendy; Fatema Nader
Journal:  J Hepatol       Date:  2019-07-04       Impact factor: 25.083

3.  Fructose stimulated de novo lipogenesis is promoted by inflammation.

Authors:  Jelena Todoric; Giuseppe Di Caro; Saskia Reibe; Darren C Henstridge; Courtney R Green; Alison Vrbanac; Fatih Ceteci; Claire Conche; Reginald McNulty; Shabnam Shalapour; Koji Taniguchi; Peter J Meikle; Jeramie D Watrous; Rafael Moranchel; Mahan Najhawan; Mohit Jain; Xiao Liu; Tatiana Kisseleva; Maria T Diaz-Meco; Jorge Moscat; Rob Knight; Florian R Greten; Lester F Lau; Christian M Metallo; Mark A Febbraio; Michael Karin
Journal:  Nat Metab       Date:  2020-08-24

Review 4.  From NASH to HCC: current concepts and future challenges.

Authors:  Quentin M Anstee; Helen L Reeves; Elena Kotsiliti; Olivier Govaere; Mathias Heikenwalder
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-07       Impact factor: 46.802

Review 5.  Mechanisms and disease consequences of nonalcoholic fatty liver disease.

Authors:  Rohit Loomba; Scott L Friedman; Gerald I Shulman
Journal:  Cell       Date:  2021-05-13       Impact factor: 41.582

Review 6.  The role of dectin-1 in health and disease.

Authors:  Namarta Kalia; Jatinder Singh; Manpreet Kaur
Journal:  Immunobiology       Date:  2021-02-05       Impact factor: 3.144

Review 7.  Dectin-1 Signaling Update: New Perspectives for Trained Immunity.

Authors:  Pablo Mata-Martínez; Marta Bergón-Gutiérrez; Carlos Del Fresno
Journal:  Front Immunol       Date:  2022-02-14       Impact factor: 7.561

Review 8.  Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis.

Authors:  Santosh Kumar; Qihua Duan; Rongxue Wu; Edward N Harris; Qiaozhu Su
Journal:  Adv Drug Deliv Rev       Date:  2021-07-16       Impact factor: 15.470

Review 9.  Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease.

Authors:  David Højland Ipsen; Jens Lykkesfeldt; Pernille Tveden-Nyborg
Journal:  Cell Mol Life Sci       Date:  2018-06-23       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.